Encore ECPG Reports Strong Q1 2026 Revenue NA EPS Beats European Central Bank and Bank of England Poised to Hold Rates as Stagflation Risks Mount Marathon Petroleum Analyst Sentiment Split on Refining Giants Prospects Ferrovial SE FER Down 154 How Low Could It Go 20260515 Intelligent IPM Q1 2026 Results Fall Short EPS 004 Revenue NA Salesforces India Expansion Under Arundhati Bhattacharya How a Book Shaped a Banking Icons Tech Pivot Pacira BioSciences PCRX Q1 2026 Earnings Surprise EPS 060 Up Significant Markets Shrug Off Hot April Inflation Data as Core CPI and PPI Surprise to the Upside UKGulf Trade Agreement Hailed as Monumental Achievement by Bahrain Minister Corporate Enthusiasm for Prediction Markets Persists Amid Regulatory Uncertainty Tony Blairs Economic Diagnosis Hits Mark but AIFocused Prescription Draws Skepticism Nifty and Nifty Bank Futures Encounter Sustained Resistance Amid Mixed Positioning Signals PlayStation Plus Price Hikes Draw Criticism From Subscribers Amid Growing Gaming Subscription Costs Synopsys Faces Potential Decline in Q2 Earnings as Analysts Adjust Forecasts CBIO Q1 2026 Earnings Narrower Loss Surprises Pipeline Progress Continues IMCR Q1 2026 Earnings Surprise Profitability Defies Expectations with No Reported Revenue FGBI Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Declines Despite Strong Performance AEP Q1 2026 Earnings Earnings Beat Estimates Driven by Operational Strength Nuvalent Inc NUVL Q1 2026 Earnings Slightly Wider Loss No Revenue Yet as PreClinical Pipeline Progresses Crexendo CXDO Q1 2026 Earnings EPS Surges Past Estimates by 256 Amid Sparse Revenue Disclosure John Hancock Diversified Income Fund HEQ Modest Uptick Amid Steady Support Levels Smurfit WestRock SW Holds Steady Near MidRange as Investors Eye Resistance Levels Richtech Robotics RR Holds Steady Near Key Support Level Shinhan Financial Group SHG Edges Higher as Support Holds Firm Eaton Vance Enhanced Equity Income Fund II EOS Hovers Near Support Amid Low Volatility Trumps AntiWeaponization Fund Faces Opposition from Nearly Half of MAGA Supporters Poll Shows QURE Q1 2026 Earnings Narrowed Loss Beats Estimates as Gene Therapy Pipeline Steadies Alnylam Pharmaceuticals Slips Amid Sector Volatility Support and Resistance in Focus